Universe Pharmaceuticals Inc Total Liabilities

Latest as of December 2025: $13.17 Million USD

Universe Pharmaceuticals Inc total liabilities. Based on the latest financial reports, Universe Pharmaceuticals Inc (UPC) has total liabilities worth $13.17 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Universe Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Universe Pharmaceuticals Inc (2018–2025)

Total liabilities of Universe Pharmaceuticals Inc from 2018 to 2025. This chart illustrates how Universe Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Universe Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Universe Pharmaceuticals Inc Competitors by Total Liabilities

The table below lists competitors of Universe Pharmaceuticals Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Magnum Goldcorp Inc V:MGI	Canada	CA$144.78K
Blockchaink2 Corp V:BITK	Canada	CA$1.58 Million
Carr's Group plc LSE:CARR	UK	GBX49.08 Million
ALPHAHELIX MOL.DIAGN. SK1 F:4MB	Germany	€12.31 Million
Kooth plc LSE:KOO	UK	GBX7.67 Million
Real Messenger Corporation Ordinary Shares NASDAQ:RMSG	USA	$349.01K
E2Gold Inc V:ETU	Canada	CA$1.80 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Universe Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see UPC total asset value.

Liquidity & Leverage Metrics

Universe Pharmaceuticals Inc Total Liabilities Ratios Explained

Universe Pharmaceuticals Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Universe Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Universe Pharmaceuticals Inc (2018–2025)

The table below shows the annual total liabilities of Universe Pharmaceuticals Inc from 2018 to 2025.

Year	Total Liabilities	Change
2025-09-30	$13.17 Million	-41.32%
2024-09-30	$22.45 Million	+63.22%
2023-09-30	$13.75 Million	+5.01%
2022-09-30	$13.10 Million	+16.83%
2021-09-30	$11.21 Million	+40.11%
2020-09-30	$8.00 Million	+46.74%
2019-09-30	$5.45 Million	-70.36%
2018-09-30	$18.40 Million	--

About Universe Pharmaceuticals Inc

NASDAQ:UPC USA Drug Manufacturers - Specialty & Generic

Market Cap

$839.37K

Market Cap Rank

#30791 Global

#6261 in USA

Share Price

$1.49

Change (1 day)

-3.25%

52-Week Range

$1.49 - $12.18

All Time High

$84.75